Literature DB >> 35311578

Inflammatory Monocytes Promote Granuloma-Mediated Control of Persistent Salmonella Infection.

Julie A Bettke1,2, Jason W Tam1,2, Valeria Montoya1,2, Brian P Butler3, Adrianus W M van der Velden1,2.   

Abstract

Persistent infections generally involve a complex balance between protective immunity and immunopathology. We used a murine model to investigate the role of inflammatory monocytes in immunity and host defense against persistent salmonellosis. Mice exhibit increased susceptibility to persistent infection when inflammatory monocytes cannot be recruited into tissues or when they are depleted at specific stages of persistent infection. Inflammatory monocytes contribute to the pathology of persistent salmonellosis and cluster with other cells in pathogen-containing granulomas. Depletion of inflammatory monocytes during the chronic phase of persistent salmonellosis causes regression of already established granulomas with resultant pathogen growth and spread in tissues. Thus, inflammatory monocytes promote granuloma-mediated control of persistent salmonellosis and may be key to uncovering new therapies for granulomatous diseases.

Entities:  

Keywords:  CCR2+ cells; Salmonella; chronic; granuloma; host response; infection; inflammatory monocyte; pathogenesis; persistent

Mesh:

Substances:

Year:  2022        PMID: 35311578      PMCID: PMC9022522          DOI: 10.1128/iai.00070-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  71 in total

Review 1.  Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.

Authors:  John S Gunn; Joanna M Marshall; Stephen Baker; Sabina Dongol; Richelle C Charles; Edward T Ryan
Journal:  Trends Microbiol       Date:  2014-07-22       Impact factor: 17.079

2.  Typhoid hepatitis.

Authors:  S Ramachandran; J J Godfrey; M V Perera
Journal:  JAMA       Date:  1974-10-14       Impact factor: 56.272

3.  CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties.

Authors:  Jason W Tam; Amy L Kullas; Patricio Mena; James B Bliska; Adrianus W M van der Velden
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

Review 4.  Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions.

Authors:  J R Forbes; P Gros
Journal:  Trends Microbiol       Date:  2001-08       Impact factor: 17.079

5.  Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.

Authors:  Ting Jia; Natalya V Serbina; Katharina Brandl; Maggie X Zhong; Ingrid M Leiner; Israel F Charo; Eric G Pamer
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

6.  Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area.

Authors:  M M Levine; R E Black; C Lanata
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

7.  Granulomatous inflammatory response in a case of typhoid fever.

Authors:  S Bharadwaj; J T Anim; F Ebrahim; A Aldahham
Journal:  Med Princ Pract       Date:  2009-04-06       Impact factor: 1.927

8.  Inflammatory monocytes provide a niche for Salmonella expansion in the lumen of the inflamed intestine.

Authors:  Patrick A McLaughlin; Julie A Bettke; Jason W Tam; Jesse Leeds; James B Bliska; Brian P Butler; Adrianus W M van der Velden
Journal:  PLoS Pathog       Date:  2019-07-15       Impact factor: 7.464

9.  The Salmonella Secreted Effector SarA/SteE Mimics Cytokine Receptor Signaling to Activate STAT3.

Authors:  Kyle D Gibbs; Erica J Washington; Sarah L Jaslow; Jeffrey S Bourgeois; Matthew W Foster; Robyn Guo; Richard G Brennan; Dennis C Ko
Journal:  Cell Host Microbe       Date:  2019-12-31       Impact factor: 21.023

Review 10.  Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.

Authors:  Nicholas A Feasey; Gordon Dougan; Robert A Kingsley; Robert S Heyderman; Melita A Gordon
Journal:  Lancet       Date:  2012-05-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.